Research advances in geriatric depression

World Psychiatry

Volumn 8, Issue 3, 2009, Pages 140-149

  Alexopoulos, George S ^a   Kelly Jr , Robert E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cardiovascular disease; Cerebrovascular disease; Geriatric depression; Late life depression; Late onset depression; Magnetic resonance imaging; Post stroke depression; Treatment; Vascular depression

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; DULOXETINE; LAMOTRIGINE; VENLAFAXINE; ZIPRASIDONE;

ANISOTROPY; BLOOD OXYGENATION; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITIVE THERAPY; DEPRESSION; DIFFUSION TENSOR IMAGING; ECOSYSTEM FOCUSED THERAPY; ELECTROCONVULSIVE THERAPY; FRACTIONAL ANISOTROPY; GENETIC ANALYSIS; GERIATRICS; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; MAGNETIC SEIZURE THERAPY; MEDICAL RESEARCH; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOTHERAPY; REVIEW; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; VAGUS NERVE; VAGUS NERVE STIMULATION; VOLUMETRY;

EID: 70350498775     PISSN: 17238617     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2051-5545.2009.tb00234.x     Document Type: Review

References (159)

1. Moussavi S, Chatterji S, Verdes E et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-858 (Pubitemid 47362344)
2. Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Med Sci 2003;58:249-265
3. Alexopoulos GS, Meyers BS, Young RC et al. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-922
4. Jacoby RJ, Levy R, Bird JM. Computed tomography and the outcome of affective disorder a follow-up study of elderly patients. Br J Psychiatry 1981;139:288-292 (Pubitemid 11029863)
5. Roth M, Kay DW. Affective disorders arising in the senium. II. Physical disability as an aetiological factor. J Ment Sci 1956;102:141-150
6. Alexopoulos GS, Vrontou C, Kakuma T et al. Disability in geriatric depression. Am J Psychiatry 1996;153:877-885
7. Alexopoulos GS, Meyers BS, Young RC et al. The course of geriatric depression with "reversible dementia": a controlled study. Am J Psychiatry 1993;150:1693-1699
8. Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: age of onset and dementia. Biol Psychiatry 1993;34:141-145 (Pubitemid 23257739)
9. Alexopoulos GS, Young RC, Shindledecker RD. Brain computed tomography findings in geriatric depression and primary degenerative dementia. Biol Psychiatry 1992;31:591-599
10. Coffey CE, Figiel GS, Djang WT et al. Leukoencephalopathy in elderly depressed patients referred for ECT. Biol Psychiatry 1988;24:143-161
11. Jacoby RJ, Levy R. Computed tomography in the elderly. 3. Affective disorder. Br J Psychiatry 1980;136:270-275
12. Post F. The significance of affective disorders in old age. London: Institute of Psychiatry, 1962.
13. Post F, Schulman K. New views on old age affective disorder. In: Aire T (ed). Recent advances in psychogeriatrics. New York: Churchill Livingstone, 1985:119-140
14. Starkstein SE, Robinson RG. Depression in cerebrovascular disease. In: Starkstein SE, Robinson RG (eds). Depression in neurological disease. Baltimore: Johns Hopkins University Press, 1993:28-49.
15. Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry 1977;40:1018-1020 (Pubitemid 8253479)
16. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. Br J Psychiatry 1987;151:52-56
17. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology 1989;39:349-354
18. Robinson RG. Neuropsychiatric consequences of stroke. Ann Rev Med 1997;48:217-229
19. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003;54:376-387
20. Hackett ML, Yapa C, Parag V et al. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005;36:1330-1340 (Pubitemid 40798764)
21. Peterson JC, Charlson ME, Williams-Russo P et al. New postoperative depressive symptoms and long-term cardiac outcomes after coronary artery bypass surgery. Am J Geriatr Psychiatry 2002;10:192-198 (Pubitemid 34685631)
22. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003;54:227-240 (Pubitemid 37267853)
23. Whyte EM, Mulsant BH, Vanderbilt J et al. Depression after stroke: a prospective epidemiological study. J Am Geriatr Soc 2004;52:774-778 (Pubitemid 38596498)
24. Thomas AJ, Kalaria RN, O'Brien JT. Depression and vascular disease: what is the relationship? J Affect Disord 2004;79:81-95.
25. Alexopoulos GS, Kiosses DN, Klimstra S et al. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am J Geriatr Psychiatry 2002;10:98-106.
26. Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. Am J Psychiatry 2002;159:1119-1126
27. Elderkin-Thompson V, Kumar A, Bilker WB et al. Neuropsychological deficits among patients with late-onset minor and major depression. Arch Clin Neuropsychol 2003;18:529-549 (Pubitemid 36593200)
28. Sobin C, Sackeim HA. Psychomotor symptoms of depression. Am J Psychiatry 1997;154:4-17.
29. Sheline YI, Barch DM, Garcia K et al. Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry 2006;60:58-65. (Pubitemid 43912563)
30. Alexopoulos GS. Geriatric mood disorders. In: Sadock BJ, Sadock VA (eds). Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 8th ed. Baltimore: Lippincott Williams & Wilkins, 2005:3677-87.
31. Nebes RD, Pollock BG, Houck PR et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res 2003;37:99-108.
32. Murphy CF, Alexopoulos GS. Longitudinal association of initiation/perseveration and severity of geriatric depression. Am J Geriatr Psychiatry 2004;12:50-56
33. Butters MA, Becker JT, Nebes RD et al. Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry 2000;157:1949-1954
34. Bhalla RK, Butters MA, Mulsant BH et al. Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry 2006;14:419-427
35. Alexopoulos GS, Kiosses DN, Murphy C et al. Executive dysfunction, heart disease burden, and remission of geriatric depression. Neuropsychopharmacology 2004;29:2278-2284 (Pubitemid 39578921)
36. Aizenstein HJ, Butters MA, Figurski JL et al. Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 2005;58:290-296
37. Alexopoulos GS, Meyers BS, Young RC et al. Executive dysfunction and long-term outcomes of geriatric depression. Arch Gen Psychiatry 2000;57:285-290
38. Kalayam B, Alexopoulos GS. Prefrontal dysfunction and treatment response in geriatric depression. Arch Gen Psychiatry 1999;56:713-718 (Pubitemid 29357732)
39. Alexopoulos GS, Kiosses DN, Heo M et al. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005;58:204-210 (Pubitemid 41112268)
40. Alexopoulos GS. Depression in the elderly. Lancet 2005;365:1961-1970
41. Alexopoulos GS, Meyers BS, Young RC et al. Clinically defined vascular depression. Am J Psychiatry 1997;154:562-565
42. Salloway S, Correia S, Boyle P et al. MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression. J Neurol Sci 2002;203-204:227-233 (Pubitemid 35287403)
43. Sneed JR, Roose SP, Keilp JG et al. Response inhibition predicts poor antidepressant treatment response in very old depressed patients. Am J Geriatr Psychiatry 2007;15:553-563
44. Janssen J, Pol HE, Schnack HG et al. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. Int J Geriatr Psychiatry 2007;22:468-474 (Pubitemid 46831691)
45. Steffens DC, Conway CR, Dombeck CB et al. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. J ECT 2001;17:45-49
46. Simpson SW, Jackson A, Baldwin RC et al. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment. Int Psychogeriatr 1997;9:257-275
47. Simpson S, Baldwin RC, Jackson A et al. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 1998;28:1015-1026 (Pubitemid 28458458)
48. Smith GS, Gunning-Dixon FM, Lotrich FE et al. Translational research in late-life mood disorders: implications for future intervention and prevention research. Neuropsychopharmacology 2007;32:1857-1875
49. Almeida OP, Waterreus A, Hankey GJ. Preventing depression after stroke: results from a randomized placebo-controlled trial. J Clin Psychiatry 2006;67:1104-1109 (Pubitemid 44230882)
50. Baron M, Mendlewicz J, Klotz J. Age-of-onset and genetic transmission in affective disorders. Acta Psychiatr Scand 1981;64:373-380
51. Brodaty H, Luscombe G, Parker G et al. Early and late onset depression in old age: different aetiologies, same phenomenology. J Affect Disord 2001;66:225-236 (Pubitemid 32907529)
52. Krishnan KR, Hays JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997;154:497-501.
53. Krishnan KR, Taylor WD, McQuoid DR et al. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol Psychiatry 2004;55:390-397
54. Kendler KS, Fiske A, Gardner CO et al. Delineation of two genetic pathways to major depression. Biol Psychiatry (in press).
55. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531 (Pubitemid 26403928)
56. Caspi A, Sugden K, Moffitt TE et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389 (Pubitemid 36877077)
57. Hoefgen B, Schulze TG, Ohlraun S et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005;57:247-251 (Pubitemid 40187368)
58. Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet 2004;14:121-129 (Pubitemid 39281818)
59. Comings DE, MacMurray JP, Gonzalez N et al. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab 1999;67:248-253 (Pubitemid 29390175)
60. Nakatani D, Sato H, Sakata Y et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J 2005;150:652-658 (Pubitemid 41396493)
61. Alexopoulos GS, Gunning-Dixon FM, Murphy CF et al. Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. J Affect Disord (in press).
62. Rogers MA, Bradshaw JL, Pantelis C et al. Frontostriatal deficits in unipolar major depression. Brain Res Bull 1998;47:297-310. (Pubitemid 29042630)
63. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986;9:357-381
64. Rajkowska G, Miguel-Hidalgo JJ, Wei J et al. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 1999;45:1085-1098 (Pubitemid 29236550)
65. Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998;95:13290-13295
66. Ballmaier M, Toga AW, Blanton RE et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004;161:99-108. (Pubitemid 38419314)
67. Coffey CE, Wilkinson WE, Weiner RD et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 1993;50:7-16.
68. Drevets WC, Price JL, Simpson JR, Jr. et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827
69. Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry 2000;48:791-800.
70. MacQueen GM, Campbell S, McEwen BS et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003;100:1387-1392 (Pubitemid 36184011)
71. Drevets WC. Neuroimaging abnormalities in the amygdala in mood disorders. Ann NY Acad Sci 2003;985:420-444 (Pubitemid 36521131)
72. Gunning-Dixon FM, Brickman AM, Cheng JC et al. Aging of cerebral white matter a review of MRI findings. Int J Geriatr Psychiatry 2009;24:109-117
73. Murphy CF, Gunning-Dixon FM, Hoptman MJ et al. White-matter integrity predicts stroop performance in patients with geriatric depression. Biol Psychiatry 2007;61:1007-1010
74. Vermeer SE, Koudstaal PJ, Oudkerk M et al. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002;33:21-25 (Pubitemid 34052178)
75. Longstreth WT, Jr., Bernick C, Manolio TA et al. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998;55:1217-1225 (Pubitemid 28427493)
76. Fujikawa T, Yamawaki S, Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 1993;24:1631-1634 (Pubitemid 23315866)
77. Coffey CE, Figiel GS, Djang WT et al. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 1990;147:187-189
78. Tupler LA, Krishnan KR, McDonald WM et al. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. J Psychosom Res 2002;53:665-676
79. Steffens DC, Krishnan KR, Crump C et al. Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. Stroke 2002;33:1636-1644 (Pubitemid 34619971)
80. Krishnan KR, Goli V, Ellinwood EH et al. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 1988;23:519-522 (Pubitemid 18064902)
81. Coffey CE, Figiel GS, Djang WT et al. White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly. J Neuropsychiatry Clin Neurosci 1989;1:135-144
82. O'Brien JT, Firbank MJ, Krishnan MS et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symptoms in older people: the LADIS study. Am J Geriatr Psychiatry 2006;14:834-841
83. Thomas AJ, O'Brien JT, Davis S et al. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 2002;59:785-792 (Pubitemid 35001143)
84. Breteler MM, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252
85. Fazekas F, Niederkorn K, Schmidt R et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988;19:1285-1288 (Pubitemid 18244455)
86. Liao D, Cooper L, Cai J et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997;16:149-162 (Pubitemid 27215864)
87. van Swieten JC, Geyskes GG, Derix MM et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 1991;30:825-830
88. Ylikoski R, Ylikoski A, Erkinjuntti T et al. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-824 (Pubitemid 23229307)
89. Steffens DC, Bosworth HB, Provenzale JM et al. Subcortical white matter lesions and functional impairment in geriatric depression. Depress Anxiety 2002;15:23-28 (Pubitemid 34160262)
90. Joynt KE, Whellan DJ, O'Connor CM. Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003;54:248-261
91. Thomas AJ, Ferrier IN, Kalaria RN et al. Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. Am J Psychiatry 2000;157:1682-1684
92. Lotrich FE, Ferrell RE, Rabinovitz M et al. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism. Biol Psychiatry 2009;65:344-348
93. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31. (Pubitemid 43083561)
94. Teper E, O'Brien JT. Vascular factors and depression. Int J Geriatr Psychiatry 2008;23:993-1000.
95. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-226
96. Whyte EM, Pollock BG, Wagner WR et al. Influence of serotonin- transporter-linked promoter region polymorphism on platelet activation in geriatric depression. Am J Psychiatry 2001;158:2074-2076
97. Ellison JM, Kyomen HH, Verma S (eds). Mood disorders in later life, 2nd ed. New York: Informa Healthcare, 2009.
98. Hoptman MJ, Gunning-Dixon FM, Murphy CF et al. Structural neuroimaging research methods in geriatric depression. Am J Geriatr Psychiatry 2006;14:812-822
99. Huettel SA, Song AW, McCarthy G. Functional magnetic resonance imaging. Sunderland: Sinauer, 2004.
100. Beckmann CF, Smith SM. Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 2004;23:137-152
101. Calhoun VD, Adali T, McGinty VB et al. fMRI activation in a visual-perception task: network of areas detected using the general linear model and independent components analysis. Neuroimage 2001;14:1080-1088
102. McKeown MJ, Makeig S, Brown GG et al. Analysis of fMRI data by blind separation into independent spatial components. Hum Brain Mapp 1998;6:160-188 (Pubitemid 28247339)
103. Alexopoulos GS, Gunning-Dixon FM, Latoussakis V et al. Anterior cingulate dysfunction in geriatric depression. Int J Geriatr Psychiatry 2008;23:347-355 (Pubitemid 351566330)
104. Alexopoulos GS, Murphy CF, Gunning-Dixon FM et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 2008;165:238-244
105. Alexopoulos GS, Kiosses DN, Choi SJ et al. Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry 2002;159:1929-1932 (Pubitemid 35283262)
106. Davidson RJ, Irwin W, Anderle MJ et al. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003;160:64-75.
107. Fu CH, Williams SC, Cleare AJ et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004;61:877-889
108. Gormley N. ECT should be treatment option in all cases of refractory depression. BMJ 1998;316:233. (Pubitemid 28122278)
109. O'Connor MK, Knapp R, Husain M et al. The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry 2001;9:382-390
110. Tew JD, Jr., Mulsant BH, Haskett RF et al. Acute efficacy of ECT in the treatment of major depression in the old-old. Am J Psychiatry 1999;156:1865-1870
111. American Psychiatric Association Task Force. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging, 2nd ed. Washington: American Psychiatric Association, 2001.
112. Sackeim HA, Prudic J, Devanand DP et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000;57:425-434 (Pubitemid 30257256)
113. McCall WV, Reboussin DM, Weiner RD et al. Titrated moderately suprathreshold vs. fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 2000;57:438-444
114. Sackeim HA, Prudic J, Nobler MS et al. Effects of pulse width and electrode placement on the efficacy and cognitive effects of elec- troconvulsive therapy. Brain Stimulation 2008;1:71-83. (Pubitemid 351698629)
115. Sienaert P, Vansteelandt K, Demyttenaere K et al. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy. J Affect Disord 2009;116:106-112
116. Repetitive transcranial magnetic stimulation (TMS) for medication-resistant depression. Med Lett Drugs Ther 2009;51:11-12
117. George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry 1999;56:300-311 (Pubitemid 29165173)
118. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65:193-207.
119. Jorge RE, Moser DJ, Acion L et al. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008;65:268-276 (Pubitemid 351342443)
120. Kosel M, Frick C, Lisanby SH et al. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 2003;28:2045-2048
121. Lisanby SH, Schlaepfer TE, Fisch HU et al. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001;58:303-305
122. White PF, Amos Q, Zhang Y et al. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg 2006;103:76-80. (Pubitemid 44036035)
123. Kirov G, Ebmeier KP, Scott AI et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008;193:152-155
124. Rush AJ, Marangell LB, Sackeim HA et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005;58:347-354
125. Harden CL, Pulver MC, Ravdin LD et al. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1:93-99
126. Elger G, Hoppe C, Falkai P et al. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203-210 (Pubitemid 30829566)
127. George MS, Rush AJ, Marangell LB et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005;58:364-373 (Pubitemid 41219704)
128. Husain MM, Trevino K, Whitworth LA et al. The role of vagus nerve stimulation as a therapy for treatment-resistant depression. Depression: Mind and Body 2006;2:114-119
129. Benabid AL. Deep brain stimulation for Parkinson's disease. Curr Opin Neurobiol 2003;13:696-706. (Pubitemid 37518457)
130. Lozano AM, Dostrovsky J, Chen R et al. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 2002;1:225-231 (Pubitemid 37159184)
131. Mayberg HS, Lozano AM, Voon V et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-660 (Pubitemid 40320700)
132. Lozano AM, Mayberg HS, Giacobbe P et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008;64:461-467
133. McIntyre CC, Savasta M, Kerkerian-Le Goff L et al. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004;115:1239-1248 (Pubitemid 38596707)
134. Schlaepfer TE, Cohen MX, Frick C et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008;33:368-377 (Pubitemid 350243349)
135. Goodman WK, Insel TR. Deep brain stimulation in psychiatry: concentrating on the road ahead. Biol Psychiatry 2009;65:263-266
136. van Schaik DJ, van Marwijk HW, Beekman AT et al. Interpersonal psychotherapy (IPT) for late-life depression in general practice: uptake and satisfaction by patients, therapists and physicians. BMC Fam Pract 2007;8:52.
137. Gellis ZD, McGinty J, Horowitz A et al. Problem-solving therapy for late-life depression in home care: a randomized field trial. Am J Geriatr Psychiatry 2007;15:968-978
138. Alexopoulos GS, Katz IR, Reynolds CF, 3rd et al. Pharmacotherapy of depression in older patients: a summary of the expert consensus guidelines. J Psychiatr Pract 2001;7:361-376
139. Thompson LW. Cognitive-behavioral therapy and treatment for late-life depression. J Clin Psychiatry 1996;57(Suppl. 5):29-37. (Pubitemid 26182271)
140. Cuijpers P, van Straten A, Smit F. Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials. Int J Geriatr Psychiatry 2006;21:1139-1149 (Pubitemid 46029217)
141. Alexopoulos GS, Raue PJ, Kanellopoulos D et al. Problem solving therapy for the depression-executive dysfunction syndrome of late life. Int J Geriatr Psychiatry 2008;23:782-788
142. Alexopoulos GS, Bruce ML. A model for intervention research in late-life depression Int J Geriatr Psychiatry (in press).
143. Robinson RG, Jorge RE, Moser DJ et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299:2391-2400
144. Kotila M, Numminen H, Waltimo O et al. Depression after stroke: results of the FINNSTROKE Study. Stroke 1998;29:368-372 (Pubitemid 28086678)
145. Alexopoulos GS, Sirey JA, Raue PJ et al. Outcomes of depressed patients undergoing inpatient pulmonary rehabilitation. Am J Geriatr Psychiatry 2006;14:466-475
146. Borson S, McDonald GJ, Gayle T et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992;33:190-201.
147. Bair MJ, Robinson RL, Katon W et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-2445 (Pubitemid 37385786)
148. American Pain Society. Pain: current understanding of assessment, management, and treatments. www.ampainsoc.org/ce/downloads/npc/npc.pdf.
149. Raskin J, Wiltse CG, Siegal A et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry 2007;164:900-909 (Pubitemid 46972905)
150. Steffens DC, Chung H, Krishnan KR et al. Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2008;39:857-862 (Pubitemid 351619570)
151. Wu RR, Zhao JP, Guo XF et al. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study. Am J Psychiatry 2008;165:352-358
152. Demyttenaere K, Jaspers L. Bupropion and SSRI-induced side effects. J Psychopharmacol 2008;22:792-804.
153. Bowden CL, Calabrese JR, Ketter TA et al. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 2006;163:1199-1201
154. Baptista T, ElFakih Y, Uzcategui E et al. Pharmacological management of atypical antipsychotic-induced weight gain. CNS Drugs 2008;22:477-495 (Pubitemid 351693690)
155. Alexopoulos GS. Interventions for depressed elderly primary care patients. Int J Geriatr Psychiatry 2001;16:553-559 (Pubitemid 32618847)
156. Bruce ML, Ten Have TR, Reynolds CF, 3rd et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA 2004;291:1081-1091
157. Alexopoulos GS, Katz IR, Bruce ML et al. Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry 2005;162:718-724
158. Unutzer J, Katon W, Williams JW, Jr. et al. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care 2001;39:785-799 (Pubitemid 33686262)
159. Unutzer J, Katon W, Callahan CM et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA 2002;288:2836-2845 (Pubitemid 35425069)